“…Half of the programs were from the United States (US; n = 11) (28,30,31,33,(36)(37)(38)(39)(40)(41)(42)46,49,50) with the remainder from Europe (n = 7) (26,27,29,32,34,35,47,48,55), Australia (n = 2) (43-45,51-54) and the United Kingdom (UK; n = 1) (25). The programs were evaluated as controlled trials (n = 15), both randomized (n = 10) (28,30,31,(34)(35)(36)(37)(38)(39)41,(43)(44)(45)48,55) and non-randomized (n = 5) (26,27,29,42,47,(51)(52)(53)(54), and as pre-post case series (n = 6) (25,…”